Cite
APA Citation
Ritchlin, C. T., Kavanaugh, A., Merola, J. F., Schett, G., Scher, J. U., Warren, R. B., Gottlieb, A. B., Assudani, D., Bedford-Rice, K., Coarse, J., Ink, B., & McInnes, I. B. (2019). bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. Lancet, 395(10222), 427–440. http://access.bl.uk/ark:/81055/vdc_100099963680.0x000047